1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]
 
IJPMBS 2024 Vol.13(4): 136-143
doi: 10.18178/ijpmbs.13.4.136-143

Research Progress of NK Cell-Based Immunotherapy for Tumors

Yiming Chen
Jurong Country Garden School, Nanjing, Jiangsu, China
Email: 2042558527@qq.com

Manuscript received September 6, 2024; revised September 30, 2024; accepted October 8, 2024; published December 25, 2024.

Abstract—Nowadays, immunotherapy plays an important role in the comprehensive treatment of tumors. As an immune cell, Natural Killer (NK) cells have many advantages in tumor immunotherapy and will become a potential tumor immunotherapy. This dissertation will investigate three types of NK cell-based immunotherapies, namely NK cell infusion therapy, immune checkpoint blockade therapy, and CAR-NK therapy. The potential of immunotherapy based on NK cells has been demonstrated in various clinical trial cases. At the same time, it shows that there are still some key questions about NK cells, such as how to prepare NK cells, the selection of NK cell donors, and how to improve the function of NK cells. This article reviews the research progress of NK cell-based immunotherapy, which is expected to provide new ideas for the clinical treatment of tumors.
 
Keywords—CAR-NK, immune checkpoint blockade, NK cell, tumor immunotherapy 

Cite: Yiming Chen, "Research Progress of NK Cell-Based Immunotherapy for Tumors," International Journal of Pharma Medicine and Biological Sciences, Vol. 13, No. 4, pp. 136-143, 2024.
 
Copyright © 2024 by the authors. This is an open access article distributed under the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits use, distribution and reproduction in any medium, provided that the article is properly cited, the use is non-commercial and no modifications or adaptations are made.

Copyright © 2012-2025. International Journal of Pharma Medicine and Biological Sciences. All Rights Reserved
​E-mail: ijpmbs@ejournal.net
Published by